What does Allerinvest do?
ALLERINVEST specializes in innovative solutions for allergy management and prevention. The company focuses on developing products and services that enhance the quality of life for individuals with allergies. Through research and collaboration, ALLERINVEST aims to lead advancements in the allergy care industry.
- Sectors
- Holding companies
- Activities
- Signals
-
Reporting lossesReporting losses € -5K
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -5KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -5KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 2.13MStrong equity provides a buffer against setbacks.
Low riskLow risk 95.2%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 11.05A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
- Shareholders
- Innovation Fund 25,12%, Inventures 22,25%
- Investments
- Acar'up 100%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-4K
|
€
-3K
|
€
-26K
|
€
-2K
|
|
|
€
-5K
|
€
-4K
|
€
-27K
|
€
-3K
|
|
|
€
-5K
|
€
-4K
|
€
-1.31M
|
€
-15K
|
|
|
€
2.13M
|
€
2.13M
|
€
1.99M
|
€
3.00M
|
|
|
95.18%
|
97.24%
|
97.69%
|
96.39%
|
|
|
€
108K
|
€
60K
|
€
47K
|
€
112K
|
|
|
€
19
|
€
889
|
€
2K
|
€
13K
|
Publications 17
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 16/04/2024
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions - Demissions, Nominations 10/05/2023
- Demissions, Nominations 21/06/2022
- Demissions, Nominations 16/06/2021
- Demissions, Nominations 30/06/2020
Frequently asked questions
Answers to the most common questions about Allerinvest, based on official government data and the filed annual accounts.
What is the VAT number of Allerinvest?
The VAT number of Allerinvest is BE0644.917.069.
When was Allerinvest established?
Allerinvest was founded in 28-12-2015.
What is the official address of Allerinvest?
The official address of Allerinvest is Veldkapelgaarde 30 Sint-Lambrechts-Woluwe 1200.
What is the legal form of Allerinvest?
The juridical form of Allerinvest is Public limited company (NV/SA).
What is the annual revenue of Allerinvest?
The 2025 accounts of Allerinvest do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Allerinvest do?
ALLERINVEST specializes in innovative solutions for allergy management and prevention. The company focuses on developing products and services that enhance the quality of life for individuals with allergies. Through research and collaboration, ALLERINVEST aims to lead advancements in the allergy care industry.
Is Allerinvest a reliable company?
Allerinvest is a registered Rechtspersoon with company number 0644.917.069 and can be verified through the official CBE database.
What is the credit limit of Allerinvest?
The estimated credit limit of Allerinvest is €103,748.
Is Allerinvest still active?
Allerinvest currently has the status "Normal situation" and is active.